| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Propanc Biopharma Inc (OTCQB: PPCB)
PPCB Technical Analysis
5
| As on 4th Jun 2025 PPCB STOCK Price closed @ 4.57 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.02 & Strong Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PPCBSTOCK Price
| Open | 4.57 | Change | Price | % |
| High | 4.57 | 1 Day | 1.77 | 63.21 |
| Low | 3.07 | 1 Week | 1.66 | 57.04 |
| Close | 4.57 | 1 Month | 4.24 | 1282.79 |
| Volume | 2036 | 1 Year | 4.52 | 9040.00 |
| 52 Week High 11.00 | 52 Week Low 0.00 | ||||
OTCQB USA Most Active Stocks
| BMIX | 0.01 | % |
| FMCC | 4.94 | 12.53% |
| TSSI | 17.62 | -1.29% |
| INVU | 0.02 | 100.00% |
| ALPP | 3.56 | -100.00% |
| ALPP | 3.56 | -100.00% |
| CBDS | 0.06 | -25.00% |
| VKIN | 0.23 | 0.00% |
| SRNA | 2.78 | 14.88% |
| KOAN | 0.01 | % |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| PPCB Daily Charts |
PPCB Intraday Charts |
Whats New @ Bazaartrend |
PPCB Free Analysis |
|
|
PPCB Important Levels Intraday
| RESISTANCE | 7.46 |
| RESISTANCE | 6.53 |
| RESISTANCE | 5.96 |
| RESISTANCE | 5.39 |
| SUPPORT | 3.75 |
| SUPPORT | 3.18 |
| SUPPORT | 2.61 |
| SUPPORT | 1.68 |
PPCB Forecast August 2025
| 4th UP Forecast | 4.74 |
| 3rd UP Forecast | 4.69 |
| 2nd UP Forecast | 4.65 |
| 1st UP Forecast | 4.62 |
| 1st DOWN Forecast | 4.52 |
| 2nd DOWN Forecast | 4.49 |
| 3rd DOWN Forecast | 4.45 |
| 4th DOWN Forecast | 4.4 |
PPCB Weekly Forecast
| 4th UP Forecast | 4.97 |
| 3rd UP Forecast | 4.84 |
| 2nd UP Forecast | 4.76 |
| 1st UP Forecast | 4.68 |
| 1st DOWN Forecast | 4.46 |
| 2nd DOWN Forecast | 4.38 |
| 3rd DOWN Forecast | 4.30 |
| 4th DOWN Forecast | 4.17 |
PPCB Forecast2025
| 4th UP Forecast | 25.77 |
| 3rd UP Forecast | 18.97 |
| 2nd UP Forecast | 14.77 |
| 1st UP Forecast | 10.57 |
| 1st DOWN Forecast | -1.43 |
| 2nd DOWN Forecast | -5.63 |
| 3rd DOWN Forecast | -9.83 |
| 4th DOWN Forecast | -16.63 |
Propanc Biopharma Inc ( OTCQB USA Symbol : PPCB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PPCB Business Profile
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Address: 302, 6 Butler Street, Camberwell, VIC, Australia, 3124
� 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service